IMNM · Immunome Inc
United States · RS rating 18 · As of 2026-10-14
| Price | 17.20 USD |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 7 / 17 / 75 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 21 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -35.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +42.3% |
| Market cap (USD) | $2.6B |